356 related articles for article (PubMed ID: 30177605)
21. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
22. Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.
Liu KC; Yeo Y
Mol Pharm; 2013 May; 10(5):1695-704. PubMed ID: 23510114
[TBL] [Abstract][Full Text] [Related]
23. Characterization of folic acid-PAMAM conjugates: drug loading efficacy and dendrimer morphology.
Chanphai P; Tajmir-Riahi HA
J Biomol Struct Dyn; 2018 May; 36(7):1918-1924. PubMed ID: 28605947
[TBL] [Abstract][Full Text] [Related]
24. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery.
Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F
Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810
[TBL] [Abstract][Full Text] [Related]
25. Partial Surface Modification of Low Generation Polyamidoamine Dendrimers: Gaining Insight into their Potential for Improved Carboplatin Delivery.
Nguyen DH; Bach LG; Nguyen Tran DH; Cao VD; Nguyen TNQ; Le TTH; Tran TT; Thi TTH
Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31159469
[TBL] [Abstract][Full Text] [Related]
26. l-Serine-modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier.
Matsuura S; Katsumi H; Suzuki H; Hirai N; Hayashi H; Koshino K; Higuchi T; Yagi Y; Kimura H; Sakane T; Yamamoto A
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10511-10516. PubMed ID: 30249662
[TBL] [Abstract][Full Text] [Related]
27. In vitro enzymatic stability of dendritic peptides.
Yang H; Lopina ST
J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
[TBL] [Abstract][Full Text] [Related]
28. Poly(amido amine) dendrimers in oral delivery.
Yellepeddi VK; Ghandehari H
Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
[TBL] [Abstract][Full Text] [Related]
29. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
[TBL] [Abstract][Full Text] [Related]
30. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
[TBL] [Abstract][Full Text] [Related]
31. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
Nasr M; Najlah M; D'Emanuele A; Elhissi A
Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of TPGS-Grafted Polyamidoamine Dendrimer for Enhanced Piperine Brain Delivery and Pharmacokinetics.
Singh A; Mhaske A; Shukla R
AAPS PharmSciTech; 2022 Aug; 23(7):236. PubMed ID: 36002713
[TBL] [Abstract][Full Text] [Related]
33. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.
Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S
Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309
[TBL] [Abstract][Full Text] [Related]
34. Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers.
Lyu Z; Ding L; Tintaru A; Peng L
Acc Chem Res; 2020 Dec; 53(12):2936-2949. PubMed ID: 33275845
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin model.
Winnicka K; Wroblewska M; Sosnowska K; Car H; Kasacka I
Drug Des Devel Ther; 2015; 9():1367-77. PubMed ID: 25834395
[TBL] [Abstract][Full Text] [Related]
36. Codendrimer from polyamidoamine (PAMAM) and oligoethylene dendron as a thermosensitive drug carrier.
Guo Y; Zhao Y; Zhao J; Han M; Zhang A; Wang X
Bioconjug Chem; 2014 Jan; 25(1):24-31. PubMed ID: 24295126
[TBL] [Abstract][Full Text] [Related]
37. Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM.
Vergara-Jaque A; Comer J; Monsalve L; González-Nilo FD; Sandoval C
J Phys Chem B; 2013 Jun; 117(22):6801-13. PubMed ID: 23642174
[TBL] [Abstract][Full Text] [Related]
38. A comparative study on solubility improvement of tetracycline and dexamethasone by poly(propylene imine) and polyamidoamine dendrimers: An insight into cytotoxicity and cell proliferation.
Najafi F; Salami-Kalajahi M; Roghani-Mamaqani H; Kahaie-Khosrowshahi A
J Biomed Mater Res A; 2020 Mar; 108(3):485-495. PubMed ID: 31682311
[TBL] [Abstract][Full Text] [Related]
39. Analysis of polyamidoamine dendrimers by isoelectric focusing.
Upadhaya SK; Swanson DR; Tomalia DA; Sharma A
Anal Bioanal Chem; 2014 Jan; 406(2):455-8. PubMed ID: 24247550
[TBL] [Abstract][Full Text] [Related]
40. The interaction mechanism between lipopeptide (daptomycin) and polyamidoamine (PAMAM) dendrimers.
Chanvorachote B; Qiu J; Muangsiri W; Nimmannit U; Kirsch LE
J Pept Sci; 2015 Apr; 21(4):312-9. PubMed ID: 25694356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
